These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 772721

  • 1. 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.
    Ungerstedt U.
    Pharmacol Ther B; 1976; 2(1):37-40. PubMed ID: 772721
    [No Abstract] [Full Text] [Related]

  • 2. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
    Fuxe K, Ungerstedt U.
    Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332
    [No Abstract] [Full Text] [Related]

  • 3. Further evidence for the stimulation of rat brain dopamine receptors by ergometrine.
    Woodruff GN, Elkhawad AO, Crossman AR.
    J Pharm Pharmacol; 1974 Jun; 26(6):455-6. PubMed ID: 4154992
    [No Abstract] [Full Text] [Related]

  • 4. Effects of chronic morphine treatment on dopamine-mediated turning behaviour in rats and mice with 6-hydroxydopamine-induced unilateral nigro-striatal lesions.
    Slater P, Crossman AR.
    Neuropharmacology; 1980 Mar; 19(3):289-95. PubMed ID: 7191487
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The anatomical substrate of the turning behaviour seen after lesions in the nigrostriatal dopamine system.
    Garcia-Munoz M, Patino P, Wright AJ, Arbuthnott GW.
    Neuroscience; 1983 Jan; 8(1):87-95. PubMed ID: 6300729
    [Abstract] [Full Text] [Related]

  • 7. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD, Creese I.
    Adv Neurol; 1975 Jan; 9():81-92. PubMed ID: 1170717
    [No Abstract] [Full Text] [Related]

  • 8. The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.
    Costall B, Naylor RJ, Pycock C.
    J Pharm Pharmacol; 1975 Dec; 27(12):943-6. PubMed ID: 2668
    [No Abstract] [Full Text] [Related]

  • 9. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.
    Björklund A, Stenevi U.
    Brain Res; 1979 Nov 30; 177(3):555-60. PubMed ID: 574053
    [No Abstract] [Full Text] [Related]

  • 10. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B, Naylor RJ, Pycock C.
    Eur J Pharmacol; 1976 Feb 30; 35(2):276-83. PubMed ID: 942921
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
    Creese I, Iversen SD.
    Psychopharmacol Bull; 1975 Oct 30; 11(4):12-3. PubMed ID: 1197588
    [No Abstract] [Full Text] [Related]

  • 14. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H, Llorens C, Schwartz JC, Gros C, Dray F.
    Brain Res; 1978 Aug 04; 151(2):392-8. PubMed ID: 209865
    [No Abstract] [Full Text] [Related]

  • 15. Changed eating and locomotor behaviour in the rat after 6-hydroxydopamine lesions to the substantia nigra.
    Brook C, Iversen SD.
    Neuropharmacology; 1975 Feb 04; 14(2):95-105. PubMed ID: 1171387
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT, Fibiger HC.
    Eur J Pharmacol; 1974 Dec 04; 29(2):249-52. PubMed ID: 4613562
    [No Abstract] [Full Text] [Related]

  • 19. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
    Ungerstedt U, Ljungberg T, Steg G.
    Adv Neurol; 1974 Dec 04; 5():421-6. PubMed ID: 4531217
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.